By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danish bioinformatics firms CLC bio announced today a deal with Aros Applied Biotechnology for the use of CLC bio's enterprise platform for analyzing next-generation sequencing data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.